申请人:Montréal Heart Institute
公开号:US20210369688A1
公开(公告)日:2021-12-02
The present invention relates to compounds of Formula I, pharmaceutically acceptable salts, solvates or formulations thereof. Compounds of Formula I increase significantly low density lipoprotein receptor and are useful for preventing and treating of elevated cholesterol.